Syntal Capital Partners, LLC Merck & Co., Inc. Transaction History

Syntal Capital Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	SELL	$102.94 - $114.86 $1.69 Million - $1.89 Million	-16,416 Reduced 58.68%	11,560 $1.23 Million
Q4 2022 Jan 31, 2023	SELL	$87.44 - $112.11 $17,138 - $21,973	-196 Reduced 0.7%	27,976 $3.1 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $29,331 - $32,951	347 Added 1.25%	28,172 $2.45 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $2.32 Million - $2.63 Million	27,825 New	27,825 $2.55 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $528,756 - $576,363	-6,950 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $53,357 - $62,334	-764 Reduced 9.9%	6,950 $582,000
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $536,740 - $612,183	7,714 New	7,714 $641,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Syntal Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Syntal Capital Partners, LLC with notifications on news.